Feb 22, 2024 / 01:30PM GMT
Sara Bonstein - Insmed Incorporated - CFO
Good day and welcome to the Innospec, Inc., fourth-quarter and full year 2023 financial results conference call. (Operator Instructions) I would like to advise all participants this call is being recorded. Thank you. I'd now like to welcome Brian Dunn, Head of Investor Relations to begin the conference. Brian, over to you.
Bryan Dunn - Insmed Incorporated - Head of IR
Thank you, Gavin. Good day, everyone, and welcome to today's conference call to discuss Insmed's Fourth Quarter 2023 financial results and provide a business update. I am joined today by Will Lewis Chair and Chief Executive Officer, and Sarah bonds day and Chief Financial Officer, who will each provide prepared remarks before we open it up for your questions. Before we start, please note that today's call will include forward looking statements based on our current expectations. These statements represent our judgment as of today and inherently involve risks and uncertainties that may cause actual results to differ materially from the results discussed.
Q4 2023 Insmed Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot